http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Hunt for Gene Therapy Breakthroughs
-
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Hunt for Gene Therapy Breakthroughs
-
Genprex to Present at Sachs 5th Annual Immuno-Oncology BD&L and Investment Forum
-
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Promising New Gene Therapies
-
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Promising New Gene Therapies
-
Genprex Retains Addison Whitney for Drug Nomenclature Branding
-
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Gene Therapies for Cancer Treatment
-
Genprex (GNPX) Featured in NetworkNewsAudio Broadcast Discussing Gene Therapy Programs on the Cusp of Curing the Incurable
-
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Cancer and Gene Therapy Treatment
-
Genprex Collaborators Report Positive TUSC2 and Checkpoint Blockade Preclinical Data at the 2019 AACR Annual Meeting
-
Genprex Provides Clinical, Corporate, and Financial Update for the Year Ending December 31, 2018
-
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Advanced Medical Cancer Therapy
-
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Innovative Cancer Treatments
-
Genprex Inc. Discusses Plans to Expand Clinical Trials in Fight Against Cancer in Exclusive Audio Interview with NetworkNewsWire
-
Genprex to Present at ARM Cell & Gene Therapy Investor Day in New York City
-
Genprex Strengthens Senior Team and Continues to Advance Operations
-
Genprex (GNPX) Announces John N. Bonfiglio PhD to Board
-
Genprex Appoints John N. Bonfiglio, PhD, to Board of Directors
-
Genprex to Present at NobleConXV in Fort Lauderdale, Florida
-
Genprex to Present at Biotech Showcase™ 2019 in San Francisco
-
Genprex to Launch Investors Website and Increase Emphasis on Investor Relations in 2019
-
Genprex to Present at the 11th Annual LD Micro Main Event
-
Genprex Provides Clinical and Corporate Update for Third Quarter 2018
-
Genprex to Present at Upcoming Investor Conferences
-
Genprex Provides Clinical and Corporate Update for Second Quarter 2018
-
Genprex To Present At The Singular Research Summer Solstice 2018 Conference
-
Genprex To Present At Upcoming Investor And Industry Conferences
-
Genprex Selects Accenture To Support Acceleration Of Oncoprex Clinical Development Program
-
Genprex Appoints Julien Pham, MD, MPH As President To Lead Commercialization Of Oncoprex Immunogene Therapy

